| Lauren Thatcher, LGPC | |
|
5550 Friendship Blvd Ste 590, Chevy Chase, MD 20815-7310 | |
| (410) 757-2077 | |
| Not Available |
| Full Name | Lauren Thatcher |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 5550 Friendship Blvd Ste 590, Chevy Chase, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144009200 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | LGP14291 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Thatcher, LGPC 900 N Randolph St, Arlington, VA 22203-1949 Ph: () - | Lauren Thatcher, LGPC 5550 Friendship Blvd Ste 590, Chevy Chase, MD 20815-7310 Ph: (410) 757-2077 |
News Archive
Cardiovascular disease (CVD) in all its forms is the biggest cause of death across Europe. Although there is little doubt that better focus on prevention can lessen its impact, we are left with a series of fundamental questions to what extent can the impact be reduced, and at what cost. And are the health benefits of prevention worth the investment. The EUROASPIRE III health economics study aims to find out.
Heart rate and blood pressure regulation may hold the key to treating unexplained chronic nausea in children. In a new study by researchers at Wake Forest Baptist Medical Center, a drug commonly used to treat a condition known as orthostatic intolerance (OI), which causes dizziness and occasional fainting when patients stand for long periods, was shown to reduce debilitating chronic nausea in patients.
Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Hand-held PDA devices for recording daily symptoms are helping fibromyalgia patients and their doctors better understand links between pain, emotional distress and fatigue in this complex pain disorder, according to research reported in The Journal of Pain, the peer review publications of the American Pain Society.
› Verified 3 days ago
Ms. Judy Wang, LCPC, RPT Counselor Medicare: Not Enrolled in Medicare Practice Location: 6800 Wisconsin Ave Ste 1051, Chevy Chase, MD 20815 Phone: 240-780-8793 | |
Tigisty Reda Zerislassie, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3351 Jones Bridge Rd, Chevy Chase, MD 20815 Phone: 202-247-6290 | |
Mrs. Sheila Hill, MSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 5480 Wisconsin Ave, Suite Ll7, Chevy Chase, MD 20815 Phone: 301-656-8544 Fax: 202-319-9308 | |
Julian Capon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5480 Wisconsin Avenue, Chevy Chase, MD 20815 Phone: 301-807-3416 | |
Mrs. Margo Ruth Aron, MSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 5480 Wisconsin Ave, Suite 229, Chevy Chase, MD 20815 Phone: 202-537-1325 | |
Mr. Aaron Jacob Sterling, LMSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 5480 Wisconsin Ave Ste 223, Chevy Chase, MD 20815 Phone: 130-157-6604 |